Analysis
Three IPOs moved through the pipeline within 48 hours this week, and none of them are AI infrastructure companies: Attovia Therapeutics, an early-Phase-1 biotech seeking $212.5 million; Reformation, a sustainable fashion brand pricing at up to $225 million; and GrubMarket, an AI-adjacent food supply chain company confidentially filing at a $4.5 billion valuation. Individually, none of these is the kind of headline-grabbing deal that 2026's IPO narrative has been built around -- that title belongs to SpaceX's record $75 billion offering and Anthropic and OpenAI's pending filings. But the sector breadth across biotech, consumer apparel, and food-tech in a single week is arguably the more important signal for the health of the broader market.
A genuine IPO window reopening isn't confirmed by one or two trophy AI deals pricing -- mega-caps with enough demand and narrative gravity can often go public even in a closed window. It's confirmed when ordinary, mid-cap companies across unrelated sectors are willing to test public markets in the same stretch, because that requires broad-based investor risk appetite rather than narrow enthusiasm for a single category. This week's mix -- an early-clinical biotech, a DTC apparel brand, and a boring-but-profitable logistics company -- is exactly that kind of breadth signal.
“The underlying numbers back it up: 210 IPOs have priced in the US through July 29, 2026, running 7.14% ahead of the same point in 2025, according to IPO tracking data.”
The underlying numbers back it up: 210 IPOs have priced in the US through July 29, 2026, running 7.14% ahead of the same point in 2025, according to IPO tracking data. That's a real year-over-year acceleration, not just a handful of large deals inflating the headline dollar figure. For VCs and founders weighing exit timing, the takeaway is that the window is open broadly enough that sector fit matters less than it did twelve months ago -- companies outside the AI narrative are finding real investor demand, which should give later-stage founders across categories more confidence in testing a 2027 listing rather than waiting for a single dominant AI theme to define what "IPO-ready" looks like.
